The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage (Q47986653)

7 February 2018

title

The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4718188

24 February 2023

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

24 February 2023

author name string

D. Tovi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4718188

24 February 2023

language of work or name

English

0 references

publication date

1 January 1973

1 reference

7 February 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0404.1973.tb01288.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0404.1973.tb01288.x/fullpdf

24 February 2023

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Acta Neurologica Scandinavica

24 February 2023

published in

1 reference

7 February 2018

volume

49

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

163-175

1 reference

7 February 2018

Experimental and Clinical Studies on AMCA, the Antifibrinolytically Active Isomer of p-Aminomethyl Cyclohexane Carboxylic Acid

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

The biological significance of fibrinolysis

24 February 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Results of surgical treatment of 200 consecutive cerebral arterial aneurysms

24 February 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Hypothermia, and interruption of carotid, or carotid and vertebral circulation, in the surgical management of intracranial aneurysms.

24 February 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Hypothermia in the surgical treatment of ruptured in tracranial aneurysms

24 February 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Mechanism of Growth and Rupture in Cerebral Berry Aneurysms

24 February 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Surgical risk as related to time of intervention in the repair of intracranial aneurysms

24 February 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Fibrinolysis in subarachnoid haemorrhage

24 February 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms

24 February 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Prognosis for patients with nonsurgically-treated aneurysms. Analysis of the Cooperative Study of Intracranial Aneurysms and Subarachnoid hemorrhage

24 February 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Surgical risk as related to time of intervention in the repair of intracranial aneurysms

24 February 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Comparative studies of fibrinolytic inhibitors in vitro

24 February 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Treatment of multiple intracranial aneurysms. Treatment of multiple intracranial aneurysms

24 February 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Antifibrinolytic therapy for intracranial aneurysms

24 February 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time.

24 February 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Effect of venous occlusion on coagulation and fibrinolytic components in normal subjects

24 February 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Report on the cooperative study of intracranial aneurysms and subarachnoid hemorrhage. Section VII. I. Evaluation of the conservative management of ruptured intracranial aneurysms

24 February 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

The use of antifibrinolytic substances in ruptured intracranial aneurysms

24 February 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Preoperative management of patients with ruptured intracranial aneurysms

24 February 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Intracranial aneurysms in the neurosurgical clinics in Japan.

24 February 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Increased fibrinolytic activity and fibrin degradation products after experimental intracerebral haemorrhage

24 February 2023

31

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study.

24 February 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

Fibrinolytic activity of the cerebrospinal fluid after subarachnoid haemorrhage.

24 February 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1973.TB01288.X

24 February 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4718188

24 February 2023

1 reference

7 February 2018